Skip to main content
Utváření digitální budoucnosti Evropy

Meet the finalists of the eHealth Adoption Awards 2017

  • NEWS ARTICLE
  • Publikation 26 april 2017

What are the best success stories when it comes to deploying eHealth in Europe? The eHealth Adoption Awards, supported by the European Commission, recognise the work of both adopters and their technological suppliers in implementing digital health innovation for the benefit of patients.

Logo eHealth Adoption Awards

Out of a total of 40 applications, the adoption-supplier teams that have been chosen for the final are:

MyDiabetesMyWay and NHS Scotland (UK)

MyDiabetesMyWay (MDMW) is a diabetes platform, integrating both patient home-recorded data and data from primary and secondary care and laboratories. This online portal empowers and supports people with diabetes in self-managing their disease. MDMW has been running since 2008, was developed by University Of Dundee and funded by the Scottish Government.

MDMW includes a complete multifunctional tool for communication, reporting and evaluating care outcomes so clinical parameters can improve. "The knowledge provided helps me to understand the normal parameters and where I stand/can improve", said a patient.

Video

NephroFlow and AZ Sint-Lucas (Ghent, Belgium)

NephroFlow is the first dialysis information system that effectively bridges treatment planning and monitoring processes with an intelligent mobile workflow in the dialysis room. At the initiative of the AZ Sint-Lucas hospital in Ghent, the system transformed the way the nephrology ward delivers instructions to nurses, captures results during sessions and facilitates communication between the different team members.

NephroFlow eliminates many of the nurses' administrative activities on which they used to spend an avarage time of 60,5 minutes per shift.

Video

Ergo/National Public Health System Ireland

PISCES (Providing Individualised Services and Care for in Epilepsy) is a cloud based EHR solution, created by clinicians that are involved in the longitudinal care pathway for epilepsy. The solution offers the ability to store and represent the full sequenced genome as well as the geneticist's opinion of the epilepsy and the neurological conditions leading to the type of epilepsy.

The results are best quantified through a real story. A patient over 30 years old who had been under the care of the epilepsy team his entire life, had at least one seizure every single day of his life. A change of diet was suggested for this patient to reduce the levels of calcium intake that were recognised from the sequenced genome. Within a short number of days this patient had the first day of his life without a seizure.

Video

Which team has made the greatest contribution to the advancement of eHealth? Stay-tuned for the voters' decision on May 11, 2017 during eHealth Week in Malta. The winning team will receive a trophy during that day's plenary session (14:00-15:00 CET) handed over by Miguel Gonzalez Sancho, Head of Unit ICT for Health, Wellbeing & Ageing (DG Connect, European Commission).

You can also vote!

Do you have a favourite? During the pitching session "Successful Implementations: eHealth Adoption Award Finalists" on Thursday 11 May starting at 10:30am, you can vote via the eHealth Week mobile app. You will be asked to take part in a Live Poll. When prompted please access the Live Polling option in the menu, select the session you are in and submit your vote.

Background

These awards give visibility and recognition to European adopters of cutting-edge innovation in eHealth, while inspiring other organisations to improve the delivery of health and care-related services with the support of innovative technology.

Teams of European adopters and IT companies that have jointly implemented an eHealth innovation with successful outputs were eligible to apply. By eHealth it is understood the use of IT solutions for health and care and may cover: digital health, active and healthy ageing, social care, mHealth, wearables, etc. Biotech and medical devices for hospital use (e.g., PET, TAC) are excluded.

More information